Embecta Corp. (NASDAQ:EMBC) Announces $0.15 Quarterly Dividend

Embecta Corp. (NASDAQ:EMBC) declared a quarterly dividend on Thursday, February 5th. Stockholders of record on Friday, February 27th will be paid a dividend of 0.15 per share on Tuesday, March 17th. This represents a c) dividend on an annualized basis and a dividend yield of 5.7%. The ex-dividend date of this dividend is Friday, February 27th.

Embecta has a payout ratio of 21.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Embecta to earn $3.07 per share next year, which means the company should continue to be able to cover its $0.60 annual dividend with an expected future payout ratio of 19.5%.

Embecta Stock Performance

NASDAQ:EMBC traded down $0.88 during trading hours on Thursday, hitting $10.47. 1,649,586 shares of the company’s stock traded hands, compared to its average volume of 636,609. The stock’s fifty day moving average price is $11.80 and its two-hundred day moving average price is $12.95. The firm has a market cap of $619.93 million, a P/E ratio of 6.42 and a beta of 1.11. Embecta has a twelve month low of $9.20 and a twelve month high of $18.12.

Embecta (NASDAQ:EMBC) last released its earnings results on Thursday, February 5th. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.04. The company had revenue of $261.20 million for the quarter, compared to analysts’ expectations of $258.07 million. Embecta had a negative return on equity of 24.62% and a net margin of 8.83%.The business’s revenue for the quarter was down .3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.65 EPS. Embecta has set its FY 2026 guidance at 2.800-3.00 EPS. On average, equities research analysts predict that Embecta will post 2.85 earnings per share for the current year.

Institutional Investors Weigh In On Embecta

Hedge funds have recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC grew its position in Embecta by 9.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 12,708 shares of the company’s stock worth $148,000 after buying an additional 1,050 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of Embecta by 7.9% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,005 shares of the company’s stock worth $145,000 after purchasing an additional 1,093 shares in the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Embecta by 5.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 21,589 shares of the company’s stock worth $209,000 after purchasing an additional 1,110 shares in the last quarter. CWM LLC increased its position in shares of Embecta by 16.0% during the second quarter. CWM LLC now owns 8,080 shares of the company’s stock valued at $78,000 after purchasing an additional 1,115 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Embecta by 2.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,323 shares of the company’s stock valued at $629,000 after purchasing an additional 1,159 shares in the last quarter. Institutional investors own 93.83% of the company’s stock.

Embecta Company Profile

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.